218 related articles for article (PubMed ID: 12767107)
1. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer.
Roth AJ; Rosenfeld B; Kornblith AB; Gibson C; Scher HI; Curley-Smart T; Holland JC; Breitbart W
Cancer; 2003 Jun; 97(11):2910-8. PubMed ID: 12767107
[TBL] [Abstract][Full Text] [Related]
2. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).
Roth A; Nelson CJ; Rosenfeld B; Warshowski A; O'Shea N; Scher H; Holland JC; Slovin S; Curley-Smart T; Reynolds T; Breitbart W
Psychosomatics; 2006; 47(4):340-7. PubMed ID: 16844894
[TBL] [Abstract][Full Text] [Related]
3. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer patients' support and psychological care needs: Survey from a non-surgical oncology clinic.
Lintz K; Moynihan C; Steginga S; Norman A; Eeles R; Huddart R; Dearnaley D; Watson M
Psychooncology; 2003 Dec; 12(8):769-83. PubMed ID: 14681951
[TBL] [Abstract][Full Text] [Related]
5. Anxiety and distress during active surveillance for early prostate cancer.
van den Bergh RC; Essink-Bot ML; Roobol MJ; Wolters T; Schröder FH; Bangma CH; Steyerberg EW
Cancer; 2009 Sep; 115(17):3868-78. PubMed ID: 19637245
[TBL] [Abstract][Full Text] [Related]
6. Do anxiety and distress increase during active surveillance for low risk prostate cancer?
van den Bergh RC; Essink-Bot ML; Roobol MJ; Schröder FH; Bangma CH; Steyerberg EW
J Urol; 2010 May; 183(5):1786-91. PubMed ID: 20299064
[TBL] [Abstract][Full Text] [Related]
7. Psychological distress and prostate specific antigen levels in men with and without prostate cancer.
Turner EL; Lane JA; Metcalfe C; Down L; Donovan JL; Hamdy F; Neal D; Vedhara K
Brain Behav Immun; 2009 Nov; 23(8):1073-8. PubMed ID: 19486654
[TBL] [Abstract][Full Text] [Related]
8. Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Macefield RC; Lane JA; Metcalfe C; Down L; Neal DE; Hamdy FC; Donovan JL
Eur J Cancer; 2009 Sep; 45(14):2569-73. PubMed ID: 19375907
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
[TBL] [Abstract][Full Text] [Related]
10. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance.
Latini DM; Hart SL; Knight SJ; Cowan JE; Ross PL; Duchane J; Carroll PR;
J Urol; 2007 Sep; 178(3 Pt 1):826-31; discussion 831-2. PubMed ID: 17632144
[TBL] [Abstract][Full Text] [Related]
11. The measurement of psychological distress in men being investigated for the presence of prostate cancer.
Awsare NS; Green JS; Aldwinckle B; Hanbury DC; Boustead GB; McNicholas TA
Prostate Cancer Prostatic Dis; 2008; 11(4):384-9. PubMed ID: 18427569
[TBL] [Abstract][Full Text] [Related]
12. Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance.
Alvisi MF; Repetto C; Rancati T; Badenchini F; Magnani T; Marenghi C; Villa S; Nicolai N; Salvioni R; Avuzzi B; Valdagni R; Bellardita L;
Tumori; 2018 Jun; 104(3):172-178. PubMed ID: 28623635
[TBL] [Abstract][Full Text] [Related]
13. Differences in health-related quality of life of prostate cancer patients based on stage of cancer.
Rosenfeld B; Roth AJ; Gandhi S; Penson D
Psychooncology; 2004 Nov; 13(11):800-7. PubMed ID: 15386638
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.
Tavlarides AM; Ames SC; Diehl NN; Joseph RW; Castle EP; Thiel DD; Broderick GA; Parker AS
Psychooncology; 2013 Jun; 22(6):1328-35. PubMed ID: 22855322
[TBL] [Abstract][Full Text] [Related]
15. Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study.
Carlsson S; Aus G; Wessman C; Hugosson J
Eur J Cancer; 2007 Sep; 43(14):2109-16. PubMed ID: 17643983
[TBL] [Abstract][Full Text] [Related]
16. Psychological distress in Japanese men with localized prostate cancer.
Namiki S; Saito S; Tochigi T; Numata I; Ioritani N; Arai Y
Int J Urol; 2007 Oct; 14(10):924-9. PubMed ID: 17880290
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk.
Berger AP; Deibl M; Steiner H; Bektic J; Pelzer A; Spranger R; Klocker H; Bartsch G; Horninger W
Prostate; 2005 Aug; 64(3):240-5. PubMed ID: 15712213
[TBL] [Abstract][Full Text] [Related]
18. Assessing anxiety in Black men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).
Nelson CJ; Starr TD; Macchia RJ; Hyacinthe L; Friedman S; Roth AJ
Support Care Cancer; 2016 Jul; 24(7):2905-11. PubMed ID: 26847348
[TBL] [Abstract][Full Text] [Related]
19. Assessing individual risk for prostate cancer.
Nam RK; Toi A; Klotz LH; Trachtenberg J; Jewett MA; Appu S; Loblaw DA; Sugar L; Narod SA; Kattan MW
J Clin Oncol; 2007 Aug; 25(24):3582-8. PubMed ID: 17704405
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level.
Leibovici D; Spiess PE; Agarwal PK; Tu SM; Pettaway CA; Hitzhusen K; Millikan RE; Pisters LL
Cancer; 2007 Jan; 109(2):198-204. PubMed ID: 17171704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
